Prevalence and diagnostic significance of serological markers of celiac disease in patients with IgA nephropathy
- Autores: Mantsaeva M.E.1, Borisov A.G1,2, Chernavsky S.V1,2, Stremoukhov A.A1
-
Afiliações:
- Russian Medical Academy of Continuous Professional Education
- Burdenko Main Military Clinical Hospital
- Edição: Volume 29, Nº 3 (2022)
- Páginas: 32-38
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/320982
- DOI: https://doi.org/10.18565/pharmateca.2022.3.32-38
- ID: 320982
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
Maria Mantsaeva
Russian Medical Academy of Continuous Professional Education
Email: mariyamantsaeva@yandex.ru
Postgraduate Student, Department of General Medical Practice and Outpatient Therapy
A. Borisov
Russian Medical Academy of Continuous Professional Education; Burdenko Main Military Clinical HospitalDepartment of General Medical Practice and Outpatient Therapy
S. Chernavsky
Russian Medical Academy of Continuous Professional Education; Burdenko Main Military Clinical HospitalDepartment of General Medical Practice and Outpatient Therapy
A. Stremoukhov
Russian Medical Academy of Continuous Professional EducationDepartment of General Medical Practice and Outpatient Therapy
Bibliografia
- Yeo S.C., Cheung C.K., Barratt J. New insights into the pathogenesis of IgA nephropathy. Pediatr Nephrol. 2018;33(5):763-77. doi: 10.1007/s00467-017-3699-z.
- Шилов Е.М., Бобкова И.Н., Колина И.Б., Камышова Е.С. Клинические рекомендации по диагностике и лечению IgA-нефропатии. Нефрология. 2015;19(6):83-92.
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1-276. doi: 10.1016/j.kint.2021.05.021.
- Papista C, Lechner S., Ben Mkaddem S., et al. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction. Kidney Int. 2015;88(2):276-85. doi: 10.1038/ki.2015.94.
- Abbad L., Monteiro R.C., Berthelot L. Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney. Mol Immunol. 2020;121:1-6. doi: 10.1016/j.molimm.2020.02.019.
- Coppo R. The intestine-renal connection in IgA nephropathy. Nephrol Dial Transplant. 2015;30(3):360-66. doi: 10.1093/ndt/gfu343.
- Koivuviita N, Tertti R., Heiro M., Metsärinne K. A case report: a patient with IgA nephropathy and coeliac disease.Complete clinical remission following gluten-free diet. NDT Plus. 2009;2(2):161-63. doi: 10.1093/ndtplus/ sfn205.
- Habura I., Fiedorowicz K., Wozniak A, et al. IgA nephropathy associated with coeliac disease. Cent. Eur J Immunol. 2019;44(1):106-8. doi: 10.5114/ceji.2019.84021.
- Coppo R., Roccatello D., Amore A., et al. Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol. 1990;33(2):72-86.
- Nurmi R., Metso M., Pörsti I., et al. Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies [published correction appears in Dig Liver Dis. 2019;51(8):1207-8. Dig Liver Dis. 2018;50(1):27-31. doi: 10.1016/j.dld.2017.09.131.
- Husby S., Murray J.A., Katzka D.A. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures. Expert Rev Gastroenterol. 2019;156(4):885-89. doi: 10.1053/j.gastro.2018.12.010.
- Al-Toma A., Volta U., Auricchio R., et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. Unit Eur Gastroenterol J. 2019;7(5):583-613. doi: 10.1177/2050640619844125.
- Collin P., Syrjänen J., Partanen J., et al. Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol. 2002;97(10):25 72- 76. doi: 10.1111/j.1572-0241.2002.06025.x.
- Nurmi R., Pohjonen J., Metso M., et al. Prevalence of Inflammatory Bowel Disease and Celiac Disease in Patients with IgA Nephropathy over Time. Nephron. 2021;145(1):78-84. Doi: 10.1 159/00051 1555.
- Costa S., Currô G., Pellegrino S., et al. Case report on pathogenetic link between gluten and IgA nephropathy. BMC. Gastroenterol. 2018;18(1):64. doi: 10.1186/s12876-018-0792-0.
- Pierucci A., Fofi C., Bartoli B, et al. Antiendomysial antibodies in Berger's disease. Am J Kidney Dis. 2002;39(6):1176-82. doi: 10.1053/ajkd.2002.33387.
- Парфенов А.И., Маев И.В., Баранов А.А. и др. Всероссийский консенсус по диагностике и лечению целиакии у детей и взрослых. Альманах клинической медицины. 2016;44(6):661-88.
- Сабельникова Е.А., Парфенов А.И., Крумс Л.М. и др. Значение метода определения деамидированного пептида глиадина в диагностике целиакии. Терапевтический архив. 2014;86(2):39-43.
- Liu E., Li M., Emery L., et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr. 2007;45(3):293-300. doi: 10.1097/MPG.0b013e31806c7b34.
Arquivos suplementares
![](/img/style/loading.gif)